Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Drug company (FDA labeler)

Novadoz Pharmaceuticals LLC

NDC labeler code: 72205

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

92Prescription medicines
248Products (NDC)
107FDA applications
1Recalls

Prescription medicines

FDA applications for these products

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
September 11, 2026ANDA219579 Dasatinib
DASATINIB		Msn
September 3, 2026ANDA220865 Tapentadol hydrochloride
TAPENTADOL HYDROCHLORIDE		Msn
September 2, 2026ANDA210245 Pomalidomide
POMALIDOMIDE		Msn
July 28, 2026ANDA214368 Sugammadex
SUGAMMADEX SODIUM		Msn
June 3, 2026ANDA217298 Tofacitinib
TOFACITINIB CITRATE		Msn
June 3, 2026ANDA217299 Tofacitinib
TOFACITINIB CITRATE		Msn
May 29, 2026ANDA209020 Oxcarbazepine
OXCARBAZEPINE		Msn
April 15, 2026ANDA219540 Glycerol phenylbutyrate
GLYCEROL PHENYLBUTYRATE		Msn
April 6, 2026ANDA211478 Dapagliflozin
DAPAGLIFLOZIN		Msn
April 6, 2026ANDA211479 Dapagliflozin and metformin hydrochloride
DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE		Msn
April 6, 2026ANDA211533 Dapagliflozin and saxagliptin
DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE		Msn
February 23, 2026ANDA214924 Brivaracetam
BRIVARACETAM		Msn
February 19, 2026ANDA214922 Brivaracetam
BRIVARACETAM		Msn
February 5, 2026ANDA215362 Bumetanide
BUMETANIDE		Msn
January 26, 2026ANDA216092 Chlorpromazine hydrochloride
CHLORPROMAZINE HYDROCHLORIDE		Msn
January 14, 2026ANDA220250 Eltrombopag
ELTROMBOPAG OLAMINE		Msn
December 11, 2025ANDA218595 Norepinephrine bitartrate
NOREPINEPHRINE BITARTRATE		Msn
November 25, 2025ANDA218178 Perampanel
PERAMPANEL		Msn
November 19, 2025ANDA218544 Nilotinib
NILOTINIB HYDROCHLORIDE		Msn
November 13, 2025ANDA214921 Brivaracetam
BRIVARACETAM		Msn
November 4, 2025ANDA219539 Irbesartan
IRBESARTAN		Msn
November 3, 2025ANDA208459 Linagliptin and metformin hydrochloride
LINAGLIPTIN AND METFORMIN HYDROCHLORIDE		Msn
October 24, 2025ANDA208546 Rivaroxaban
RIVAROXABAN		Msn
September 26, 2025ANDA217398 Olmesartan medoxomil and hydrochlorothiazide
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE		Msn
July 24, 2025ANDA219863 Famotidine
FAMOTIDINE		Msn
July 16, 2025ANDA213748 Sacubitril and valsartan
SACUBITRIL AND VALSARTAN		Msn
July 11, 2025ANDA218152 Perampanel
PERAMPANEL		Msn
June 24, 2025ANDA218177 Prucalopride
PRUCALOPRIDE SUCCINATE		Msn
April 28, 2025ANDA213483 Ivabradine
IVABRADINE HYDROCHLORIDE		Msn
April 15, 2025ANDA214817 Rufinamide
RUFINAMIDE		Msn
April 8, 2025ANDA216084 Glycopyrrolate
GLYCOPYRROLATE		Msn
March 26, 2025ANDA216748 Dexrazoxane for injection
DEXRAZOXANE HYDROCHLORIDE		Msn
February 24, 2025ANDA218434 Posaconazole
POSACONAZOLE		Msn
February 24, 2025ANDA218699 Lofexidine hydrochloride
LOFEXIDINE HYDROCHLORIDE		Msn
February 14, 2025ANDA214824 Sunitinib malate
SUNITINIB MALATE		Msn
October 1, 2024ANDA217397 Nebivolol
NEBIVOLOL HYDROCHLORIDE		Msn
September 26, 2024ANDA215100 Aminocaproic acid
AMINOCAPROIC ACID		Msn
September 20, 2024ANDA215388 Clopidogrel
CLOPIDOGREL BISULFATE		Msn
September 17, 2024ANDA216727 Prazosin hydrochloride
PRAZOSIN HYDROCHLORIDE		Msn
September 13, 2024ANDA216948 Nelarabine
NELARABINE		Msn
August 6, 2024ANDA217400 Famotidine
FAMOTIDINE		Msn
May 22, 2024ANDA213879 Dabigatran etexilate
DABIGATRAN ETEXILATE MESYLATE		Msn
February 2, 2024ANDA218306 Lisdexamfetamine dimesylate
LISDEXAMFETAMINE DIMESYLATE		Msn
January 16, 2024ANDA214925 Pimavanserin tartrate
PIMAVANSERIN		Msn
December 22, 2023ANDA215379 Lacosamide
LACOSAMIDE		Msn
November 28, 2023ANDA215389 Darunavir
DARUNAVIR		Msn
November 2, 2023ANDA215365 Fluphenazine decanoate
FLUPHENAZINE DECANOATE		Msn
September 21, 2023ANDA216512 Pyridostigmine bromide
PYRIDOSTIGMINE BROMIDE		Msn
September 11, 2023ANDA217189 Fluphenazine hydrochloride
FLUPHENAZINE HYDROCHLORIDE		Msn
August 14, 2023ANDA217396 Losartan potassium
LOSARTAN POTASSIUM		Msn
July 24, 2023ANDA211901 Plerixafor
PLERIXAFOR		Msn
July 7, 2023ANDA208228 Vilazodone hydrochloride
VILAZODONE HYDROCHLORIDE		Apotex
June 26, 2023ANDA217521 Phenylephrine
PHENYLEPHRINE HYDROCHLORIDE		Be Pharms
June 21, 2023ANDA216949 Tolvaptan
TOLVAPTAN		Msn
April 20, 2023ANDA217413 Arsenic trioxide
ARSENIC TRIOXIDE		Msn
April 3, 2023ANDA214823 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE		Msn
March 9, 2023ANDA217393 Acyclovir
ACYCLOVIR		Msn
February 9, 2023ANDA215979 Lacosamide
LACOSAMIDE		Msn
January 19, 2023ANDA216728 Sirolimus
SIROLIMUS		Msn
January 18, 2023ANDA217399 Olmesartan medoxomil
OLMESARTAN MEDOXOMIL		Msn
November 18, 2022ANDA216004 Haloperidol
HALOPERIDOL		Msn
November 15, 2022ANDA215980 Levetiracetam
LEVETIRACETAM		Msn
October 7, 2022ANDA214815 Levetiracetam
LEVETIRACETAM		Msn
September 16, 2022ANDA216090 Isosulfan blue
ISOSULFAN BLUE		Msn
September 15, 2022ANDA216091 Ziprasidone
ZIPRASIDONE MESYLATE		Msn
September 9, 2022ANDA208037 Lurasidone hydrochloride
LURASIDONE HYDROCHLORIDE		Msn
September 7, 2022ANDA208256 Roflumilast
ROFLUMILAST		Msn
September 7, 2022ANDA215363 Vigabatrin
VIGABATRIN		Msn
August 4, 2022ANDA215364 Bumetanide
BUMETANIDE		Msn
July 26, 2022ANDA209622 Bortezomib
BORTEZOMIB		Msn
July 15, 2022ANDA214757 Levetiracetam
LEVETIRACETAM		Msn
June 24, 2022ANDA215113 Doxepin hydrochloride
DOXEPIN HYDROCHLORIDE		Msn
May 24, 2022ANDA212772 Pirfenidone
PIRFENIDONE		Msn
May 18, 2022ANDA216171 Pantoprazole sodium
PANTOPRAZOLE SODIUM		Be Pharms
May 2, 2022ANDA215313 Oseltamivir phosphate
OSELTAMIVIR PHOSPHATE		Msn
February 17, 2022ANDA210169 Valganciclovir
VALGANCICLOVIR HYDROCHLORIDE		Msn
February 8, 2022ANDA214641 Sildenafil
SILDENAFIL CITRATE		Msn
January 27, 2022ANDA214827 Chlorpromazine hydrochloride
CHLORPROMAZINE HYDROCHLORIDE		Msn
November 16, 2021ANDA214816 Tiagabine hydrochloride
TIAGABINE HYDROCHLORIDE		Msn
May 11, 2021ANDA213404 Clobazam
CLOBAZAM		Msn
May 10, 2021ANDA214366 Erlotinib
ERLOTINIB HYDROCHLORIDE		Msn
April 13, 2021ANDA213226 Pregabalin
PREGABALIN		Msn
March 17, 2021ANDA214650 Deferasirox
DEFERASIROX		Msn
February 18, 2021ANDA211741 Droxidopa
DROXIDOPA		Msn Pharms Inc
January 22, 2021ANDA213435 Albendazole
ALBENDAZOLE		Msn
December 18, 2020ANDA207993 Fingolimod
FINGOLIMOD HYDROCHLORIDE		Apotex
November 6, 2020ANDA212938 Aminocaproic acid
AMINOCAPROIC ACID		Msn
August 24, 2020ANDA213434 Paclitaxel
PACLITAXEL		Msn
August 18, 2020ANDA212818 Toremifene citrate
TOREMIFENE CITRATE		Msn
May 20, 2020ANDA212544 Oseltamivir phosphate
OSELTAMIVIR PHOSPHATE		Msn
April 7, 2020ANDA208596 Ticagrelor
TICAGRELOR		Msn
March 4, 2020ANDA213049 Thiotepa
THIOTEPA		Msn
January 29, 2020ANDA213220 Dofetilide
DOFETILIDE		Msn
December 30, 2019ANDA210461 Febuxostat
FEBUXOSTAT		Msn
November 20, 2019ANDA209878 Deferasirox
DEFERASIROX		Msn
September 5, 2019ANDA209965 Fosaprepitant
FOSAPREPITANT DIMEGLUMINE		Msn
August 28, 2019ANDA212265 Decitabine
DECITABINE		Msn
July 19, 2019ANDA209357 Pregabalin
PREGABALIN		Msn
July 10, 2019ANDA210686 Abiraterone acetate
ABIRATERONE ACETATE		Msn
May 22, 2019ANDA211134 Trientine
TRIENTINE HYDROCHLORIDE		Msn
May 20, 2019ANDA210688 Solifenacin succinate
SOLIFENACIN SUCCINATE		Msn
February 8, 2019ANDA211933 Atorvastatin
ATORVASTATIN CALCIUM		Msn
December 3, 2018ANDA210687 Silodosin
SILODOSIN		Msn
July 2, 2018ANDA209365 Capecitabine
CAPECITABINE		Msn
December 6, 2017ANDA209775 Clofarabine
CLOFARABINE		Msn
November 22, 2017ANDA208898 Rosuvastatin
ROSUVASTATIN CALCIUM		Msn
September 22, 2017ANDA208682 Moxifloxacin
MOXIFLOXACIN HYDROCHLORIDE		Msn

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2025

  1. December 15, 2025 · Class III · Ongoing · D-0300-2026 · Glycopyrrolate

    Failed Impurities/Degradation Specifications

    Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026

FDA Enforcement Report search → · Report an error →